2. Significant effects of treatment (F(4,20) = 112.8, p < 0.0001) and time (F(5,20) = 14.74, p < 0.0001) were observed, and also of the treatment-versus-time interaction (F(20,210) = 1.892, p < 0.05). Post hoc analysis demonstrated a dose-dependent effect in relation to percentage of the oedema (2.689 < t < 10.02, p < 0.05). However, the intermediate doses (12.5 and 25 μg) were not significantly different when compared to each other. The minimum dose that produced significant oedema was 12.5 μg, and observed, in almost all doses tested, was a progressive increase in venom-induced

Screening Library high throughput oedema during the one-hour experiment. Bradykinin (0.53 μg/mL) and S. cyanea crude venom (50 μg/mL) induced contractions and similar muscular tension in the guinea-pig ileum segments ( Fig. 3A, B). Captopril (0.22 μg/mL) administered alone had no effect,

as already expected, however, when in association with bradykinin or with crude venom, it potentiated their contraction effect ( Fig. 3C, D). These effects were totally reversible after rinsing the preparation ( Fig. 3E). The results demonstrated that S. cyanea crude venom presented only a slight hemorrhagic activity at the assayed doses (data not shown). No hemorrhagic GS-7340 purchase halo was observed in the 50 μg dose. In the 200 μg dose, three from five rats presented some hemorrhagic activity, with a mean halo of 4.76 mm. S. cyanea wasp venom caused a dose-dependent haemolytic activity on human erythrocytes, as Silibinin shown in Fig. 4. The calculated HC50 was 0.025 μg/μL for human O positive erythrocytes. The S.

cyanea venom was tested against both Gram-positive and Gram-negative bacteria (E. faecalis and E. coli, respectively). At 100 μg, the venom presented a 93% growth inhibition against both bacteria, and at 50 μg it presented an 83% growth inhibition against E. faecalis and an inhibition of 13% against E. coli. Lower doses did not show antibacterial activity. In Latin America, especially Brazil, the human casualties caused by accidents with wasp venom are neglected and unfortunately there are no epidemiological studies providing sufficient information of this nature. The two federal agencies responsible for collecting information on health facilities – SINAN (Sistema de Informação de Agravos de Notificação) and SINITOX (Sistema Nacional de Informações Tóxico-Farmacológicas) – provide this data together with that of other venomous animals, preventing public access to clinical and epidemiological information of this specific injury. Human accidents involving Hymenoptera are characterized by two situations: the first occurs in the case of one or few bites, and the second in the event of attacks by swarms. The clinical symptoms may vary from local inflammatory reactions to more severe allergic reactions, which can lead to anaphylactic shock (de Medeiros and França, 2003). Mortality is generally related to multiple bites and serious systemic toxic manifestations induced by the venom inoculated.